Skip to main content
  • Saved

Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol - PubMed

Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/32187462/

Reductions in LDL cholesterol levels of approximately 50% were obtained with inclisiran, administered subcutaneously every 6 months. More injection-site adverse events occurred with inclisiran than with placebo. (Funded by the Medicines Company; ORION-10 and ORION-11 ClinicalTrials.gov numbers, NCT0 ...